Genentech and Roche announced that an interim analysis of a Phase III study of Avastin (bevacizumab) plus paclitaxel chemotherapy…
WebProWorld
Genentech and Roche announced that an interim analysis of a Phase III study of Avastin (bevacizumab) plus paclitaxel chemotherapy…